Current Issue October 2019

Landos Biopharma’s promising anti-inflammation drug moves into Phase II trials

  •  | 
by Tim Thornton
Article image

Landos Biopharma’s anti-inflammation drug, BT-11, moves into Phase II trials.

Read the full story →